This trial will estimate the impact of financial access to contraception on a variety of outcomes like childbearing, education, mental health, etc.
6 Primary · 0 Secondary · Reporting Duration: Up to 3 year post-enrollment
Active Control
Experimental Treatment
5000 Total Participants · 2 Treatment Groups
Primary Treatment: Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-December 31, 2021) · No Placebo Group · N/A
Age 18 - 35 · Female Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: